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2352ABSTRACT
Background. Patients in the immediate post-operative liver transplantation (LxT) period
can develop respiratory and functional complications. In the postoperative months, these
functions tend to improve. Nevertheless, there are few studies that evaluate precisely
and specifically respiratory function in post-LxT long-term after surgery. The objective
of the study was to describe the respiratory profile of patients 1 to 6 months after LxT,
accompanied by LxT outpatients.
Methods. We included patients between 25 and 60 years old. We excluded patients with
chronic renal or cerebrovascular impairment, severe heart disease, and history of lung
surgery or liver re-transplantation. Evaluations were carried out on 3 occasions: 1 month, 3
months, and 6 months after LxT. The following evaluations were submitted: respiratory
muscle strength (manuvacuometer), value flows and lung volumes (spirometer), and
surface electromyography analyzing root mean square in the right (RMS-R) and left
(RMS-L) diaphragm. We analyzed MELD (Model for End-Stage Liver Disease). After
normality tests, we used the Friedman test (non-parametric values) and ANOVA
(parametric values), P  .5 with the use of SPSS 21.0.
Results. Patients (n ¼ 15) had a mean age of 53.0  7.5 years and 25.9  4.6 MELD
score. The statistically significant value obtained at the 3 occasions of evaluation was
RMS-R, with a decline during periods of evaluation. This can be caused by removal of the
liver, resulting in a denervation and reduction in compliance of this portion of the muscle.
Conclusions. Patients between 1 and 6 months after transplantation have a specific
respiratory profile, close to normal values. However, there are few studies on this subject,
and we suggest that more research be done.*Address correspondence to Marcela Maria Carvalho da Silva,
Av.EngenheiroAugustoFigueiredo,No.357,Apartment105,Tower
6, Campinas/SP, Brazil. E-mail: marcelacarvalhofisioterapia@
yahoo.com.brLIVER transplantation (LtX) is the only effective treat-ment for acute liver failure in advanced stages [1]. In
addition to the metabolic changes arising from the organ
failure, patients face long wait-list times [2]. Thereby, such
patients may present breathing modifications such as atel-
ectasis, pleural effusion, and low pulmonary complacency,
thus affecting the alveolar functioning and the gas exchange
before the surgery stage [1].
Soon after surgery, new functional and respiratory com-
plications usually emerge. Huang et al [1] unveiled in their
study that liver transplantation is an upper-abdominal sur-
gery, in which abdominal muscle lesions occur (rectus and
oblique) and are often associated with lung movement
(respiratory mechanics).6
.org/10.1016/j.transproceed.2016.06.010Another study corroborating this information states that
“the anesthesia, surgery trauma, and the post-op attached
conditions (incision, drainage, and catheter) have an impact
on respiratory mechanics and on patient mobility” [3].
All these factors, associated with pain, coughing diffi-
culty, and immobility, lead to post-operative pulmonary
complications.ª 2016 Elsevier Inc. All rights reserved.
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Table 1. Median or Median of Variables at Three Evaluations,
According to Respiratory Muscle Strength, Flow and Lung
Volumes, and Surface Electromyography
1 Month 3 Months 6 Months
RME
MIP (cm H2O)
† 82.5 85.0 100.0
MEP (cm H2O)
† 90.0 90.0 90.0





VEF1 (L) 75.75  15.92 78.38  16.41 86.43  10.50
RMSR (mV)*,† 34.9 31.64 37.0
sEMG
RMSL (mV)† 33.3 30.55 35.3
Abbreviations: RMS, Respiratory muscle strength; FLV, flow and lung
volumes.
*P < .05.
†Values of asymmetric median were applied.
RESPIRATORY PROFILE AFTER LIVER TRANSPLANT 2353A study on upper-abdominal surgery patients in which pre-
operative and post-operative data were assessed (first, sev-
enth, and 30th days after surgery) showed that all patients
presented a decrease in respiratory muscular performance as
well in spirometric parameters soon after surgery. However,
on the 30th day, they tended to return to their proper func-
tioning, which have been diminished before the surgery [3].
Barcelos et al [4] also evaluated the pulmonary capacity
through spiromometry and manuvacuometry for 30 patients
equally allocated into 6 groups: liver transplantation and 1,
3, 6, 9, and 12 months after the transplantation. Patients had
some increase in pulmonary capacity despite not being
statistically meaningful.
Throughout the months after surgery, patients tended to
have improvement in functions. Vital forced capacity (VFC)
and FEV1 (forced expiratory volume on the first second)
from these groups had no significant variations, demon-
strating some tendency to progressive improvement for
pulmonary capacity after transplantation. On the same
grounds, there was some improvement in maximum inspi-
ratory pressure after surgery.
Respiratory function is greatly decreased in the early
stages for the liver after transplantation, and there is a
scarcity of long-term studies for this function. It is funda-
mentally important to create a respiratory profile for an
extensive period for these patients so that we can compre-
hend the main alterations that may result and develop
intervention for exactly when these situations occur.
METHODS
Inclusion criteria for this prospective study included patients be-
tween 25 and 60 years old, submitted 1 month after LxT. Patients
were followed up by the physiotherapy team of Gastrocenter Uni-
camp, after signed informed consent was obtained. All patients who
had a history of pulmonary surgery or liver re-transplantation were
excluded, as well as those with chronic renal impairment, estab-
lished sequel of global motor function or cognitive cerebrovascular
disease, and grave heart conditions such as unstable angina or
vascular obstruction. The inability to carry out the proposed tests
was an eliminatory factor.
After the volunteer selection analysis, according to its established
inclusion and exclusion criteria, the patients were invited to a
1-month posteliver transplantation conversation at the gastro-
center outpatient facility.
Three assessment stages were defined: I) 1-month after liver
transplantation; II) 3 months after liver transplantation; and III) 6
months after liver transplantation.
Assessments consisted of an evaluation of respiratory muscle
strength, pulmonary function proof, and underlying muscle tissue
bilateral diaphragm electromyography. These were performed
throughout the whole researching protocol.
To evaluate flow and lung volumes, spirometry was measured
with the use of EasyOne Diagnostic Spirometer Word (Zurich,
Switzerland); we analyzed forced vital capacity (FVC); forced
expiratory flow 25% to 75% (FEF 25%e75%); and forced expira-
tory volume in the first second (VEF1).
To measure electrical activity of the diaphragm muscle bilateral
surface, electromyography (sEMG; EMG System of Brazil Ltd,
series 00405, model 210C; San Paulo, Brazil) was used. While thesubjects rested at 45, one electrode was placed on the xiphoid
process; another was placed 15 cm from the xiphoid process at the
right diaphragm and the third 15 cm from the xiphoid process at the
left diaphragm, with the lower ribcage margin used as reference.
The fourth was placed on the left hand to avoid interference. The
collected data of root-mean-square (RMS) right (R) and left (L)
were analyzed and recorded with the use of the notebook (Intelbras
I21, San Paulo, Brazil). Respiratory muscle strength was measured
with the use of a manometer [maximal inspiratory pressure (MIP)
and maximal expiratory pressure (MEP) in cm H2O] through
manovacuometry (300/þ300, Ger-Air San Paulo, Brazil), with
subjects in the seated position; the best result of three was recorded.
Other data collected were Model for End-Stage Liver Disease
(MELD) [5] scores and vital signs.
For descriptive statistics, the SPSS 21.0 (2012) program
(Armonk, NY, United States) was used (P < .05). Kolmogorov-
Smirnov and Shapiro-Wilk normality tests for each variable were
used. For symmetric values, mean values were used; the asymmetric
the median 1 was applied.
The Friedman statistical test was used for non-parametric values
and analysis of variance test (ANOVA) for parametric data. To
compare proportions, we used the Chi-square test.
The study was approved by the Ethics Committee of The Faculty
of Medical Sciences, State University of Campinas, eSan Paulo,
Brazil; No. 922/2009.
RESULTS
We included 15 patients in this research, which has never
been done before with such a specific sample of people. Two
patients died and 5 patients had clinical complications or
abandoned the study before completing 6 months after LxT.
In total, 38% were women and 62% were men. The average
age was 53.0  7.5 years, and the average MELD without
additional points was 25.9  4.6.
The measurements of profile respiratory evaluations are
shown in Table 1. Values were measured in 3 stages; they
were 1, 3, and 6 months after the transplantation and were
separately compared on an evaluative manner up to drawing
a respiratory profile for those patients in the course of 6
months after the transplantation.
Table 2. Demographic and Clinical Features
Pre-operative




Previous smoker (%) 50%
BMI (kg/m2) 24.34  3.49
DH (days)* 4.89
WT (months)* 7.0













AC þ HCC 12.5%
AC 37.5%
HCC 37.5%
HT þ HCC 12.5%
Donor source









Type of operation (%) 100% Orthotopic liver transplantation




exams/LFT 1 Month 3 Months 6 Months
Reference
Value
AST (U/L)* 28 22.5 22 10e30
ALT (U/L)* 27 21.5 20.5 10e40
GGT* 79.5 32 53.5 10e60
Bilirubin
(mg/dL)*
0.7 0.6 0.92 0.2e1.0
Albumin
(g/dL)
4.25  0.45 4.61  0.21 4.57  0.33 3.4e4.8
Creatinine
(mg/dL)
1.18  0.44 1.04  0.32 1.06  0.27 0.4e1.2





127.5 137 150.000 
400.000
Abbreviations: BMI, body mass index; DH, duration of hospitalization; WT,
alcoholic cirrhosis; MELD, Model for End-Stage Liver Disease; Child, classifi-
cation of Child-Turcotte-Pugh; EH, hepatic encephalopathy; AC, alcoholic
cirrhosis; HCC, hepatitis C virus cirrhosis; HT, hepatic tumor; CVA, cerebro-
vascular accident; TBI, traumatic brain injury; LFT, liver function test; AST,
aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-
glutamyl transpeptidase; INR, international normalized ratio.
*Values of asymmetric median were applied.
2354 DA SILVA, CORCHA, OLIVEIRA DA SILVA ET ALTable 2 provides the demographic and clinical charac-
teristics of patients included in the statistical analysis. No
patient studied had severe infection or acute rejection epi-
sodes during the 3 evaluations.
Complications related to health were observed: 2 patients
presented abdominal pain during the 3-month evaluation;
abdominal hernia and “started smoking again” also occurred.
DISCUSSION
The mean age was in accordance with national [4,6] and
international studies [7] in post-LxT patients.
The average value of MELD scores was higher compared
with another study [5] carried out at the same research
center showing the patients’ poor clinical state.
In the present study, we note that the measurement ob-
tained at the first evaluation, which showed the average of
MIP, is in accordance with the expected normality for the
average of the studied population. In agreement with these
data, a study with patients after cholecystectomy, which
evaluated their respiratory muscle strength, concluded that
after 10 days of surgery, the MIP returns to the initial value
of normality [2].
Concerning MEP, a study concluded that there was no
statistical difference between pre- and post-transplantation
groups (1, 3, 6, 9, and 12 months) [4]. Thus, its data are
in accordance with our results, which showed MEP
remaining the same at the 3 evaluations.
The results for the 3 evaluations of pulmonary function
tests showed no statistical difference, and thus the values
were considered normal for this population.
According to Barcelos et al [4], pathophysiological
changes in post-operative liver transplantation are observed:
volumes and vital capacity are reduced in because of the
large surgery incision and diaphragmatic dysfunction. After
7 to 10 days, this function returns to values considered
normal for the population studied.
Therefore, the values obtained in the pulmonary function
test in FVC and FEV1 resulted in no statistical difference
among the evaluations. This also occurred in another study
[4]. For this reason, we suggest a new study involving a
larger number of patients to obtain a more reliable statis-
tical result.
FEF 25%e75% values at the second evaluation were
decreased values, but without statistical difference, which
could be justified by the presented abdominal pain in this
stage.
We found no studies that discuss the use of sEMG applied
after upper-abdominal surgery or liver transplantation.
However, some findings were from right diaphragm elec-
troneuromyography, carried out on liver transplantation
waiting list candidates and developed at the same research
center [8].
This study showed the values of the average RMS (R) for
the healthy population, which were 49.1  17.6, whereas
RESPIRATORY PROFILE AFTER LIVER TRANSPLANT 2355patients’ waiting-list LxT had a value of 61.0  68.5. We
therefore concluded that the RMS (R) on patients after 1
month of transplantation showed a higher value than that
considered normal (healthy population) [8e10] RMS (R)
had a statistically significant decline in the values comparing
3 evaluation periods. This can be due to a diaphragmatic
lesion, which occurs after surgical manipulation for liver
removal, causing a denervation and reduction on compli-
ance of this portion of the muscle.
The RMS (L) showed no statistically significant differ-
ence among the 3 periods. Two hypotheses are possible and
deserve further studies. First, the liver is anatomically
located in the right portion of the diaphragm, whereas the
left manipulation is minimal, generating a minimal dia-
phragmatic change on this side. Another possibility is that
the number of patients studied is limited.
Comparing the values obtained with the pulmonary
function test and respiratory muscle strength, we verified
that they reached values close to statistical significance.
Patients between 1 to 6 months after transplantation have
a specific respiratory profile, close to normal values. How-
ever, there are few studies on this subject, and we suggest
that more research be done.
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